Related Experiment Video
Updated: Mar 26, 2026

08:29
Optogenetic Activation of Intrinsic Cardiac Autonomic Neurons in Excised Perfused Mouse Hearts
Published on: March 28, 2025
844
[Cholinergic system of the heart]
Summary
The heart
Area of Science:
- Cardiovascular Physiology
- Neurocardiology
- Cholinergic Signaling
Background:
- The heart possesses both neuronal and non-neuronal cholinergic systems.
- Non-neuronal cholinergic system involves cardiomyocytes in acetylcholine synthesis and secretion.
- Cholinergic signaling regulates cardiac function during sympathetic activation and impacts cardiomyocyte energy metabolism.
Purpose of the Study:
- To elucidate the dual origin and roles of the cardiac cholinergic system.
- To explore the mechanisms of acetylcholine action and termination in the heart.
- To investigate the therapeutic potential of cholinesterase inhibitors in cardiovascular disorders.
Main Methods:
- Review of existing literature on cardiac cholinergic system.
- Analysis of acetylcholine synthesis, secretion, and receptor interaction pathways.
- Examination of cholinesterase activity and inhibition effects.
Main Results:
- Identified neuronal and non-neuronal cholinergic pathways in the heart.
- Demonstrated acetylcholine's action via muscarinic and nicotinic receptors.
- Highlighted the role of acetylcholinesterase and butyrylcholinesterase in acetylcholine breakdown.
- Noted positive effects of cholinesterase inhibitors on cardiovascular disorders like heart failure.
Conclusions:
- The cardiac cholinergic system, from both neuronal and non-neuronal sources, plays a critical role in heart function.
- Cholinesterase inhibitors show promise for treating cardiovascular diseases, including heart failure.
Related Concept Videos
Cholinergic Receptors: Muscarinic
5.9K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
5.9K
Regulation of Heart Rates
4.5K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
4.5K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.5K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.5K
Parasympathetic Signaling
4.0K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
4.0K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
Cholinergic Receptors: Nicotinic
6.5K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
6.5K

